Characterization of Phosphatidylserine Transport to the Locus of Phosphatidylserine Decarboxylase 2 in Permeabilized Yeast*

Wen-I Wu and Dennis R. VoelkerDagger

From the Program in Cell Biology, the Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado 80206

Received for publication, November 13, 2000, and in revised form, November 29, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In yeast, nascent phosphatidylserine (PtdSer) can be transported to the mitochondria and Golgi/vacuole for decarboxylation to synthesize phosphatidylethanolamine (PtdEtn). In strains with a psd1Delta allele for the mitochondrial PtdSer decarboxylase, the conversion of nascent PtdSer to PtdEtn can serve as an indicator of lipid transport to the locus of PtdSer decarboxylase 2 (Psd2p) in the Golgi/vacuole. We have followed the metabolism of [3H]serine into PtdSer and PtdEtn to study lipid transport in permeabilized psd1Delta yeast. The permeabilized cells synthesize 3H-PtdSer and, after a 20-min lag, decarboxylate it to form [3H]PtdEtn. Formation of [3H]PtdEtn is linear between 20 and 100 min of incubation and does not require ongoing PtdSer synthesis. PtdSer transport can be resolved into a two-component system using washed, permeabilized psd1Delta cells as donors and membranes isolated by ultracentrifugation as acceptors. With this system, the transport-dependent decarboxylation of nascent PtdSer is dependent upon the concentration of acceptor membranes, requires Mn2+ but not nucleotides, and is inhibited by EDTA. High speed membranes isolated from a previously identified PtdSer transport mutant, pstB2, contain normal Psd2p activity but fail to reconstitute PtdSer transport and decarboxylation. Reconstitution with permutations of wild type and pstB2Delta donors and acceptors identifies the site of the mutant defect as the acceptor side of the transport reaction.



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The biochemical, molecular, and genetic details of the interorganelle transport of phospholipids are poorly understood. One approach to studying this problem utilizes the organelle-specific metabolism of the aminoglycerophospholipids, phosphatidylserine (PtdSer),1 phosphatidylethanolamine (PtdEtn), and phosphatidylcholine (PtdCho) outlined in Fig. 1 (1). In yeast, PtdSer is synthesized in the endoplasmic reticulum and related membranes (2). The newly formed PtdSer is subsequently decarboxylated to form PtdEtn in the mitochondria, by PtdSer decarboxylase 1 (Psd1p) (3); and in the Golgi/vacuole, by PtdSer decarboxylase 2 (Psd2p) (4). The PtdEtn resulting from the action of the decarboxylases is exported from the mitochondria and Golgi/vacuole to the endoplasmic reticulum, where it is methylated to form PtdCho (3, 5). This sequential and subcellular location-specific metabolism of the aminoglycerophospholipids provides a rapid and convenient method for assessing lipid transport in intact cells, permeabilized cells, and isolated organelles (1). This intracellular site-specific metabolism has also provided a means to develop genetic screens for new yeast strains defective in the interorganelle transport of phospholipids (6, 7). By using yeast strains with selective genetic defects in expression of either Psd1p (psd1Delta mutants) or Psd2p (psd2Delta mutants), it is possible to study lipid trafficking events to either the Golgi/vacuole or the mitochondria, respectively, using both biochemical and genetic approaches (6-8). Currently, two mutant strains have been identified using a genetic approach, and these strains identify lesions in a phosphatidylinositol 4-kinase (Stt4p) (6), and a phosphatidylinositol transfer protein (PstB2p) (7).

To complement the genetic approach and studies performed with intact cells, it is necessary to develop an in vitro assay system amenable to the addition and deletion of specific macromolecules to enable further biochemical and mechanistic dissection of the transport processes. Such a system will also allow the mixing of different donor and acceptor populations of organelles that localizes lesions topologically. Previous work by Achleitner et al. (8) described conditions for transport of nascent PtdSer from the ER to Psd1p in the mitochondria in permeabilized yeast cells. These preceding studies did not reveal conditions for transport of PtdSer from the ER to the locus of Psd2p in the Golgi/vacuole. The objectives of our current studies were to 1) define conditions for reconstituting PtdSer transport to Psd2p in permeabilized cells; 2) establish conditions for defining separable donor and acceptor compartments for PtdSer synthesis and decarboxylation; 3) identify the role of nucleotides and divalent cations in the process; and 4) apply the reconstituted system to defining the site of action of PstB2p. In this report, we now describe the characteristics of PtdSer transport from the ER to the Golgi of permeabilized cells.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chemicals-- All chemicals, including amino acids for yeast media, were purchased from Sigma or Fisher. Other components for yeast growth media were purchased from Difco. Phospholipids were obtained from Avanti Polar Lipids. Thin layer silica gel H plates were from Analtech Corp. The radioisotopes [3-3H]serine and [1-14C]serine were purchased from Amersham Pharmacia Biotech and ICN, respectively. The lipid 1-acyl,2-(6-[7-nitro-2-1,3-benzoxadiazol-4-yl)aminocaproyl-Ptd-[1'-14C]serine was synthesized using Escherichia coli PtdSer synthase (9). Protein determination reagents were obtained from either Pierce or Bio-Rad. Mouse monoclonal antibody against the 100-kDa subunit of yeast vacuolar H+-ATPase was purchased from Molecular Probes, Inc. (Eugene, OR). Other reagents used for ligand blotting were from Bio-Rad and Sigma.

Strains and Culture Conditions-- The Psd1p-deficient yeast strains PTY40 (MATalpha ura3 his3 trp1 met14 psd1Delta -1::TRP1) and WWY66 (MATalpha lys2 trp1 ura3 his3 leu2 suc2 psd1Delta -1::TRP1 pstB2::HIS3) were cultured in YPDAUE (standard YPD medium supplemented with additional adenine, uracil, and ethanolamine) (6) medium under aerobic conditions at 30 °C to an A600 between 1 and 2.

Preparation of Permeabilized Yeast Cells-- Permeabilized cells were prepared in lysis buffer (20 mM HEPES, pH 6.8, 0.15 M potassium acetate, 2 mM magnesium acetate, and 0.5 mM EDTA) following the method described by Achleitner et al. (8). In brief, yeast spheroplasts were prepared by treating cells with dithiothreitol under alkaline conditions, followed by zymolyase treatment in the presence of low glucose (0.5%) YPD (10). The resulting spheroplasts were regenerated for 20 min at 30 °C in the presence of 0.75% yeast extract, 1.5% peptone, 1% glucose, and 0.7 M sorbitol before they were washed and then resuspended in lysis buffer at a concentration of 0.5 g, wet weight/ml. The cell suspensions were divided into 0.2-0.3-ml aliquots and frozen over liquid nitrogen vapor for 15 min. The frozen cells could be stored at -80 °C for at least 3 months.

PtdSer Transport Assays-- [3H]serine was incorporated into the permeabilized cells in a reaction mixture containing 8 mM HEPES, 22 mM Tris-HCl, pH 8, 0.6 mM MnCl2, 0.8 mM magnesium acetate, 60 mM potassium acetate, 0.1 M KCl, 8.5 mM beta -chloroalanine, 0.2 mM EDTA, 0.4 mM MgCTP, 0.28 M sorbitol, 0.27 M mannitol, 50 µM L-serine, 3 µCi of [3H]serine, and the permeabilized cells equivalent to 90 µg of protein in 100 µl per reaction. The purpose of beta -chloroalanine is to inhibit extraneous metabolism of serine to sphingolipids. The assay mixture was incubated at 30 °C for 100 min unless stated otherwise. The radiolabeling reaction was stopped by the addition of 1 ml of chloroform, 1 ml of methanol, and 0.9 ml of 0.2 M KCl. The organic phase was further washed with 1.9 ml of methanol/PBS (1:0.9, v/v) twice. The resulting chloroform phase was dried under nitrogen gas, resuspended in 30 µl of chloroform/methanol (9:1, v/v), and then loaded on silica gel H thin layer chromatography plates. The plates were developed using a solvent system containing chloroform, methanol, 2-propanol, 0.25% aqueous KCl, triethylamine (30:9:25:6:18, v/v/v/v/v). Individual phospholipids were identified under ultraviolet light with authentic standards, by spraying the thin layer plates with 0.1% aqueous 8-anilino-1-naphthalenesulfonic acid. The lipid spots then were scraped into vials containing scintillation fluid, and the amount of 3H was quantified.

Preparation of Processed Donors-- Thawed permeabilized cells were centrifuged at 1000 × g for 5 min at 4 °C. The resulting low speed supernatant (LSS) was collected for reconstituting PtdSer transport or for isolating high speed supernatants (HSS) and high speed membranes (HSM) as described below. The remaining permeabilized cell pellet was washed twice with 25-fold volume of cold lysis buffer. After the second wash, the cells were resuspended in cold lysis buffer to approximately the original volume present when they were first thawed and used as the processed donors. In the indicated experiments, washed donors were preincubated with 50 µM CDP diacylglycerol (CDP-DAG), at 30 °C for 20 min. Excess CDP-DAG was removed by 1000 × g centrifugation for 5 min at 4 °C, followed by washing the cells twice with a 20-fold volume of cold lysis buffer. Prelabeled donors containing [3H]PtdSer were prepared from washed permeabilized cells incubated in the PtdSer transport assay reagents, in the presence of either MgCTP or CDP-DAG at 30 °C for 45 min. Unincorporated radiolabel was removed by centrifugation and washing with cold lysis buffer as described above for CDP-DAG-treated donors.

Preparation of LSS, HSS, and HSM-- Cellular components released from permeabilized cells were fractionated by centrifugation. LSS was collected as described above and further centrifuged at 400,000 × g for 1 h at 4 °C to obtain HSS and HSM pellet. The membrane pellet was resuspended by homogenization in cold lysis buffer using a battery-driven minihomogenizer (Kontes).

Analysis of Organelle Markers-- Fractions obtained from permeabilized cells, including processed donors, LSS, HSS, and HSM, were subjected to organelle marker analysis by either enzyme assays or by antigen detection. The ER marker, PtdSer synthase (Pssp), was measured by the method described by Carman and Bae-Lee (11). The vacuolar marker, H+-ATPase, was detected by enzyme-linked immunosorbant assays (12). The late Golgi marker, Kex2p protease, was determined by using Boc-Gln-Arg-Arg-7 amidomethyl coumarin as the substrate (13). Psd2p activity was determined as described previously (14).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

PtdSer Is Synthesized and Transported to the Locus of Psd2p in Permeabilized Yeast-- In intact cells, PtdSer is synthesized in the ER and related membranes and then transported to multiple organelles. Upon arrival at the Golgi/vacuole, the PtdSer is decarboxylated by Psd2p to form PtdEtn. PtdEtn can also be formed from nascent PtdSer by the action of Psd1p in the mitochondria. In a psd1Delta genetic background, all decarboxylation of PtdSer occurs via the action of Psd2p (see Fig. 1). We permeabilized psd1Delta cells and optimized conditions for the formation of PtdEtn by Psd2p in the Golgi/vacuole. As shown in Fig. 2, the permeabilized strain, PTY40, efficiently synthesizes [3H]PtdSer during the first 40 min of incubation, after which the level remains relatively constant, probably reflecting the consumption of endogenous CDP-DAG required for the reaction. Following a 20-30-min lag, the synthesis of [3H]PtdEtn proceeds at a linear rate between 30 and 100 min. At 100 min, ~6% of the nascent [3H]PtdSer has been converted to PtdEtn. A preliminary description of this system (7) identified the Golgi and a novel light membrane fraction as the sites of formation/accumulation of [3H]PtdEtn. These experiments provide a clear demonstration that PtdSer transport to the Psd2p can be reconstituted in permeabilized cells, making the process amenable to further powerful analysis by biochemical and genetic approaches.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Biosynthesis and transport of aminoglycerophospholipids in yeast. PtdSer is synthesized in the endoplasmic reticulum and subsequently transported to other organelles. In the mitochondria, the PtdSer is decarboxylated to form PtdEtn by PtdSer decarboxylase 1. In the Golgi/vacuole compartments, PtdEtn is formed by the action of PtdSer decarboxylase 2. PtdEtn in the mitochondria and Golgi/vacuole compartments can be subsequently exported from these organelles back to the endoplasmic reticulum for further metabolism to PtdCho by the action of PtdEtn methyltransferases. Both known and proposed mutations in the metabolic and transport process are shown in lowercase italic type: pss, PtdSer synthase; pstA, PtdSer transport A pathway; pstB, PtdSer transport B pathway; pstB1, the PtdIns-4 kinase, Stt4p; pstB2, a PtdIns transfer protein; psd1, PtdSer decarboxylase 1; psd2, PtdSer decarboxylase 2; peeA, PtdEtn export A pathway; peeB, PtdEtn export B pathway; pem1, PtdEtn methyltransferase 1; pem2, PtdEtn methyltransferase 2. The focus of this study is upon events between PtdSer synthesis and decarboxylation by Psd2p. For this report, psd1Delta mutants were used in all experiments, and the decarboxylation by the mitochondrial enzyme was completely blocked as indicated by the X through the mitochondria.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   Permeabilized yeast synthesize and transport PtdSer to the site of Psd2p. PtdSer transport was monitored by following the sequential incorporation of [3H]serine into PtdSer and PtdEtn in permeabilized cells containing a psd1Delta allele as described under "Experimental Procedures." Duplicate 100-µl aliquots were taken at each indicated time point, and radiolabeled phospholipids were extracted and analyzed by thin layer chromatography and liquid scintillation spectrometry. Data shown are means ± S.E. of at least four independent experiments.

PtdEtn Formation Requires Cellular Components Released from Permeabilized psd1Delta Yeast-- Following permeabilization, some cellular components, including cytosol and membranes, were released from the cells. The released components were initially separated from the permeabilized cells by a low speed centrifugation. We next examined the role of the released material in PtdSer transport and decarboxylation. Permeabilized cells, washed free of released cellular contents by a 1000 × g centrifugation, lost their ability to transport PtdSer to Psd2p (Fig. 3A). However, the transport activity was restored when the cells were reconstituted with their autologous LSS (Fig. 3B). The relative efficiency of PtdEtn formation after reconstitution with LSS approximated that of the unmanipulated cells. Both the rate and extent of PtdEtn formation by LSS-supplemented permeabilized cells were comparable with the results obtained in the experiments shown in Fig. 2.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   PtdSer transport can be reconstituted with washed permeabilized cells and LSS. Washed permeabilized cells were combined with a volume of LSS equivalent to that removed by centrifugation and added to the PtdSer synthesis/transport reaction mixture. PtdSer transport was followed by taking a 100-µl aliquot from the reaction mixture at the indicated time points, extracting the lipids, and analyzing them by thin layer chromatography and liquid scintillation spectrometry. PtdSer transport activity is expressed as the percentage of radiolabel incorporated into PtdEtn relative to the total radiolabel present in PtdSer plus PtdEtn at the end of a 100-min incubation. A, washed permeabilized cells alone; B, washed permeabilized cells reconstituted with LSS. The results are an average of two independent experiments performed in duplicate.

The synthesis of PtdSer in the permeabilized cells requires a CDP-DAG precursor (8). Supplementation of the permeabilized cells with CTP in the standard reaction described in Fig. 2 relies upon the action of CDP-DAG synthase as well as endogenous CDP-DAG to drive the PtdSer synthase reaction. With prolonged incubation, it is likely that the generation of CDP-DAG by the corresponding synthase will deplete the requisite phosphatidic acid pool. To circumvent the reliance upon phosphatidic acid and endogenous CDP-DAG pools, we examined the efficacy of preincubating the washed permeabilized cells with CDP-DAG. The results of these experiments are shown in Fig. 4. In these studies, we compared the formation of PtdEtn in permeabilized cells, prepared as described in Fig. 2, to that found from washed donors supplemented with MgCTP or CDP-DAG, in either the presence or absence of LSS. Under all conditions of reconstitution, the formation of PtdEtn is strongly dependent upon the addition of LSS. Preincubation of washed donors with CDP-DAG consistently gives better synthesis of PtdEtn. We believe this is due, in part, to the more proximal nature of the reactions to PtdSer formation compared with CTP supplementation. Most significantly, we also find that preincubation of the washed donors with [3H]serine and CDP-DAG followed by centrifugation to remove precursors allows us to effectively pulse-label the PtdSer pool in this compartment, thereby permitting the independent examination of events occurring between PtdSer synthesis and PtdEtn formation.



View larger version (36K):
[in this window]
[in a new window]
 
Fig. 4.   Washed donors prelabeled with [3H]serine in the presence of CDP-DAG remain competent to transport PtdSer in the presence of LSS. PtdSer transport by permeabilized cells in the standard assay (Control) was compared with that obtained by reconstitution with washed donors in either the absence (-LSS) or presence (+LSS) of LSS under the same reaction conditions. Additional comparisons were made in which washed donors were preincubated with CDP-DAG for 45 min and then washed to remove excess CDP-DAG before the addition of LSS plus [3H]serine. In a different variation, donors were preincubated with CDP-DAG plus [3H]serine for 40 min and then washed by centrifugation to remove these precursors prior to incubation with LSS. The reactions were terminated by lipid extraction, and the lipids were analyzed by thin layer chromatography and liquid scintillation spectrometry. The data are expressed as the percentage of radiolabel in PtdEtn relative to that found in PtdSer plus PtdEtn at the end of the incubation. The data are means ± S.E. for at least three experiments.

LSS Contains both Acceptor Membranes and Cytosol-- We next sought to characterize the components present in LSS and the manner in which they contribute to the transport dependent conversion of nascent PtdSer to PtdEtn. Initially, we examined the LSS for the presence of Psd2p and marker enzymes for the ER (Pssp), Golgi (Kex2p), and vacuoles (H+ATPase). As shown in Fig. 5, Pssp was retained by the washed permeabilized cells and absent from the LSS. The essentially complete absence of Pssp from the LSS makes it an ideal acceptor compartment because it is devoid of precursor synthesis. The LSS contains ~40% of the recoverable Golgi, 30% of the recoverable vacuolar marker, and 51% of the recoverable Psd2p. The total recovery of all the organelle markers between the processed permeabilized cell and its autologous LSS is between 44 and 70%, implying that significant amounts of the relevant enzymes in permeabilized cells may be either inactivated or lost during the preparation of the washed donor compartment and the LSS. Although significant amounts of the Golgi, the vacuole, and Psd2p remained with the processed donors, nascent PtdSer was not efficiently transported to these loci (Fig. 4). One likely explanation of this finding is that the factors involved in the release of the acceptor membranes may also be mechanistically relevant to the lipid transfer process.



View larger version (30K):
[in this window]
[in a new window]
 
Fig. 5.   Distribution and recovery of organelle marker enzymes among fractions derived from permeabilized cells. The distribution of organelle marker enzymes among permeabilized cells, washed donors, LSS, HSS, and HSM was determined by assaying the enzymatic activities or immunoreactivity of the indicated proteins: Pssp from endoplasmic reticulum; Kex2p from Golgi apparatus; vacuolar H+ATPase (Vac ATPase) from vacuole; Psd2p from Golgi and vacuole. Recoveries in each fraction are expressed as the percentage of values initially found in unwashed permeabilized cells (100%). The results are means ± S.E. of eight individual samples.

Acceptor Membranes Alone Are Sufficient to Reconstitute PtdSer Transport-- For further characterization, the LSS was subjected to ultracentrifugation at 400,000 × g for 1 h to generate HSM and HSS. The distribution of the ER, Golgi, and vacuolar enzymes and Psd2p in the HSM relative to other fractions is shown in Fig. 5. Almost all of the Golgi-Kex2p, vacuolar H+ATPase, and Psd2p present in the LSS was recovered in the HSM. Essentially none of these enzymes were recovered in HSS. This further partitioning of LSS allowed us to test the roles of the acceptor membranes and the cytosol individually. The specific questions that we wanted to address were whether 1) cytosol contains factors that could stimulate PtdSer transport between the donor membranes and the acceptor membranes that remained in the processed permeabilized cells, 2) isolated acceptor alone is sufficient to reconstitute PtdSer transport, and 3) both cytosol and acceptor membranes are required for PtdSer transport. When HSM alone, as the acceptor membrane, was reconstituted with processed donors, it resulted in a concentration-dependent increase of PtdSer transport activity as shown in Fig. 6. Due to the volume limitation of our assay, we were only able to test two concentrations of HSS. HSS alone weakly stimulated PtdSer transport and was significantly less effective than HSM alone. When both HSS and HSM were present to reconstitute PtdSer transport, HSS modestly enhanced PtdSer transport at low HSM concentration. However, the HSS effect was diminished when higher concentrations of HSM were present to support PtdSer transport (Fig. 6). This result demonstrates that, although there may be some cytosolic factors that can weakly stimulate PtdSer transport from the ER to the locus of Psd2p, the addition of acceptor membranes (i.e. HSM) alone, is sufficient to reconstitute the transport process in the permeabilized cell assay system.



View larger version (47K):
[in this window]
[in a new window]
 
Fig. 6.   HSM alone are sufficient to reconstitute PtdSer transport and decarboxylation. Prelabeled, washed donors derived from permeabilized cells equivalent to 90 µg of total protein were examined for PtdSer transport in the absence or the presence of the indicated amount of HSS or HSM or both. The "volume equivalent" of HSS or HSM is equal to the indicated multiple of the amount of the fraction initially isolated from 90 µg of permeabilized cell proteins. PtdSer transport activity is reported as -fold increase of PtdSer transport relative to that found for prelabeled donors alone. Results are means ± S.E. of three individual experiments.

Transport of Nascent PtdSer to Psd2p Is Nucleotide-independent-- Achleitner et al. (8) showed that PtdSer transport to yeast mitochondria is independent of ATP. However, PtdSer translocation in permeabilized mammalian cells has been demonstrated to be ATP-dependent (15-17). In addition, ATP as well as GTP are also involved in the trafficking and docking of vesicles effecting interorganelle protein transport (18-20). We examined whether the translocation of PtdSer from the ER to the Psd2p locus in yeast is nucleotide-dependent. The addition of Mg2+ salts of ATP, ADP, CTP, or UTP (at 1 mM) or of GTP, GDP, or GTPgamma S (at 0.2 mM) failed to significantly alter PtdSer transport reconstituted between the donor membranes and acceptors. These findings demonstrate that our reconstituted system does not require nucleotides as cofactors for PtdSer transport.

EDTA Inhibits PtdSer Transport to the Psd2p-containing Acceptor Membranes-- Previously, only a trace amount of PtdSer transport to the Psd2p locus could be detected in the permeabilized psd1Delta cells (8). As described under "Experimental Procedures," one alteration we made to optimize the measurement of PtdSer translocation to Psd2p was to omit EDTA from the incubations. Our success raised the question of whether PtdSer movement to the Golgi/vacuole Psd2p is sensitive to EDTA. Indeed, the addition of EDTA not only inhibited nascent PtdSer synthesis but also arrested further conversion of PtdSer into PtdEtn in unmanipulated permeabilized cells (Fig. 7). This inhibitory effect is not due to the inhibition of catalysis of Psd2p, since the enzyme does not require divalent cations for activity and is unaffected by the presence of EDTA (4). One possible explanation is that ongoing PtdSer synthesis is required for continued PtdSer transport, and the chelation of the Pssp cofactor, Mn2+ ions, by EDTA thus arrests both activities. However, this explanation is unlikely, since reconstituted PtdSer transport, using processed donors with a prelabeled PtdSer pool (Figs. 4 and 6), bypasses continuous PtdSer synthesis. The elimination of the two possibilities described above implies that EDTA may inhibit the PtdSer transport process directly. To test this hypothesis, we measured reconstituted PtdSer transport activity with prelabeled donors either in the absence or the presence of Mn2+ ions. The use of prelabeled donors allows us to exclude any effects on Pssp activity and restricts the conclusions to events occurring after PtdSer formation. As shown in Fig. 8, the transport activity was dependent upon Mn2+ ions. In addition, the transport activity was abolished when EDTA was added together with Mn2+. These results demonstrate a specific requirement for a divalent cation in the reconstituted transport reaction.



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7.   EDTA inhibits transport of PtdSer to Psd2p in unmanipulated permeabilized cells. PtdSer transport was measured using unwashed permeabilized cells as described under "Experimental Procedures" and in the legend to Fig. 2. After 45 min of incubation, either 4 mM EDTA (arrow) or buffer was added to samples, and the reactions were continued for an additional 55 min. Samples of 100 µl were removed from the reactions at the indicated times, and the extracted lipids were analyzed by thin layer chromatography and liquid scintillation spectrometry. A and B show the incorporation of radiolabel into PtdSer and PtdEtn, respectively. Data shown are from two experiments performed in duplicate.



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 8.   EDTA inhibits transport of PtdSer from prelabeled donors to HSM acceptors. PtdSer transport was reconstituted utilizing prelabeled donors and 2× volume equivalents of HSM in the presence or the absence of 0.6 mM MnCl2 and/or 4 mM EDTA. PtdSer transport activity is reported as the -fold increase in PtdSer transport relative to prelabeled donors. Results shown are means ± S.E. of 3-6 individual experiments.

PtdSer Transport Requires Manganese Ions-- Although Mn2+ was the only divalent cation added to our reconstituted washed donor/acceptor assay system described in Fig. 8, it does not elucidate whether this is a general or specific requirement for cations as cofactors for PtdSer transport. Therefore, we tested a broad range of divalent cations for their ability to stimulate PtdSer transport. The additional divalent cations examined included Mg2+, Cu2+, Ni2+, Zn2+, and Ca2+. With the exception of Ca2+, all divalent cations were tested at 1 mM. Because 1 mM Ca2+ caused extensive degradation of the labeled PtdSer pool, 50 µM Ca2+ was tested. The degradation of PtdSer by the addition of calcium may be due to the activation of a calcium-dependent phospholipase (21, 22). Among all of the ions examined, only Mn2+ ions supported PtdSer transport activity. These findings demonstrate that Mn2+ plays a unique role as a cofactor in reconstituted PtdSer transport.

The Acceptor Membrane Pool Requires Elements Other than Psd2p-- Because our assay utilizes the product of the Psd2p reaction as our transport signal, one could argue that the apparent dose-dependent transport activity of HSM is simply due to the increasing amount of Psd2p activity added to the assay system and does not truly reflect a transport process. To investigate whether such an argument is valid, we compared HSM isolated from permeabilized psd1Delta and psd1Delta /pstB2Delta cells. We have previously reported that the PSTB2 gene encodes a protein involved in the transport-dependent metabolism of PtdSer (7). Strains harboring psd1Delta /pstB2Delta mutations have normal Psd2p activity but are defective in converting PtdSer into PtdEtn in both intact and permeabilized cells (7). As shown in Fig. 9, HSM from permeabilized psd1Delta /pstB2Delta cells containing amounts of Psd2p activity comparable with HSM from psd1Delta strains failed to reconstitute PtdSer transport. Most importantly, the addition of excess Psd2p from psd1Delta /pstB2Delta strains is completely ineffective at overcoming any of the transport defect. This result indicates that the transport activity of HSM does not solely depend on the Psd2p activity but clearly involves other factors that have been specifically implicated in lipid transport by in vivo biochemical and genetic experiments. This latter finding emphatically demonstrates that the permeabilized cell system recapitulates processes found with intact cells.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 9.   The reconstituted transport system requires factors other than Psd2p to decarboxylate donor-derived PtdSer. Prelabeled psd1Delta donors were reconstituted with various amounts of HSM isolated from either psd1Delta or psd1Delta /pstB2 permeabilized cells. The Psd2p activity of either HSM was independently determined by in vitro assays utilizing 1-acyl,2-(6-[7-nitro-2-1,3-benzoxadiazol-4-yl)aminocaproyl-Ptd-[1'-14C]serine as the substrate. One unit of Psd2p activity is defined as the production of 1 pmol of 14CO2/min. PtdSer transport activity is reported as the -fold increase of PtdSer transport signal relative to the prelabeled donors alone. The results are means ± S.E. of three independent experiments.

The Permeabilized Cell System Localizes the pstB2 Defect to the Acceptor Membrane Compartment-- The experiments described above do not permit localization of the pstB2 defect. However, the ability to segregate the components of the permeabilized cell system affords the opportunity to critically test whether the pstB2 defect resides in the donor or the acceptor compartment. In these experiments, donors and acceptors were prepared from cells with either wild type or null PSTB2 alleles. The wild type donors were tested for their ability to transport nascent [3H]PtdSer to either wild type or mutant acceptors. Conversely, pstB2Delta donors were also tested for their ability to transfer [3H]PtdSer to either wild type or mutant acceptors. As shown in Fig. 10, the wild type donors could transfer PtdSer to wild type acceptors but not pstB2Delta acceptors. When pstB2Delta donors were used as a source of [3H]PtdSer, the lipid was readily transferred to wild type acceptors but not mutant acceptors. These results clearly demonstrate that the pstB2Delta -harboring strains produce competent donor membranes but incompetent acceptor membranes.



View larger version (36K):
[in this window]
[in a new window]
 
Fig. 10.   The pstB2 mutation affects acceptor membrane competence. Washed, prelabeled donor and acceptor (HSM) membranes were prepared as described in the legend to Fig. 4 using psd1Delta strains with either wild type (PSTB2) or mutant alleles (pstB2Delta ) at the second genetic locus. The donors were incubated without HSM or with HSM derived from either the PSTB2 or pstB2 strain. PtdSer transport activity was measured as the -fold increase in PtdEtn formation relative to that obtained from prelabeled donors alone. Results are means ± S.E. from three experiments.



    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The heterogeneity of the lipid composition of different organelle membranes has been known as a general principle of cell biology for decades (23). However, the molecular mechanisms and gene products responsible for generating this membrane diversity remain poorly defined. We have focused on the lipid aspect of membrane biogenesis by examining aminoglycerophospholipid synthesis in Saccharomyces cerevisiae. We have conducted both biochemical and genetic approaches to this problem in an effort to identify new genes and their products and mechanisms of actions. In this report, we describe the successful reconstitution of PtdSer transport between the ER or closely related membranes and Psd2p.

The permeabilized cell system that we developed shows time-dependent synthesis of PtdSer and PtdEtn. The level of nascent [3H]PtdSer formed plateaus after 40 min of incubation presumably due to the depletion of phosphatidic acid and CDP-DAG pools. The formation of [3H]PtdEtn proceeds after a lag of 20-30 min. This lag period is likely to comprise some feature of PtdSer movement between elements of the ER and the Golgi apparatus. Recent studies have demonstrated that most of the nascent [3H]PtdEtn is found in the Golgi and a novel light membrane fraction (7). Although 70% of the Psd2p activity colocalizes with the vacuole compartment (7), we do not see the appearance of [3H]PtdEtn in this organelle in the permeabilized cell system (7). These findings may mean that the permeabilization procedure destroys the machinery for PtdSer transport to the vacuole. Alternatively, the results may indicate that there is interorganelle cooperation between the Golgi and the vacuole with respect to the pool of Psd2p available for use in transport-dependent lipid metabolism. The formation of [3H]PtdEtn provides a relatively strong biochemical signal for PtdSer transport. This signal was probably missed in earlier studies with permeabilized cells as a consequence of inadequate Mn2+ in the reaction. We estimate that the rate of PtdEtn formation is ~20% of that occurring in intact cells.

Low speed centrifugation and washing of permeabilized cells resolves a sedimentable donor compartment capable of PtdSer synthesis but only weakly competent for decarboxylation. The LSS fraction restores the transport dependent metabolism of PtdSer to PtdEtn to the washed donors. In general, reconstitution of washed donors with LSS restores PtdEtn formation to levels between 50 and 100% of those found for unprocessed permeabilized cells. The ability to physically isolate the donor compartment permitted optimization of the conditions for synthesis of the PtdSer precursor. Preincubation of the donors with [3H]serine and CDP-DAG provided a convenient and efficient method for radiolabeling the PtdSer pool in the donors. Most importantly, this approach allowed for both temporal and physical segregation of PtdSer synthesis from its transport dependent decarboxylation. As a consequence of this refinement of the permeabilized cell system, we are more accurately able to assess requirements for events occurring after PtdSer synthesis. Subfractionation of the LSS into HSS and HSM components provides additional important details about the minimal requirements for reconstitution of PtdSer transport. These experiments provide clear evidence for the existence of two pools of Psd2p. One pool of Psd2p is retained within the permeabilized cell and functions relatively inefficiently in the decarboxylation of nascent PtdSer. In contrast, a pool of Psd2p released from the cells is more effective at the decarboxylation of PtdSer. We currently understand few of the details that characterize these two compartments containing Psd2p. However, we propose that elements of the system that are permissive for the release of Psd2p may be important components affecting PtdSer transfer between organelle domains. The current studies clearly demonstrate that the HSM derived from LSS is fully competent to import PtdSer and decarboxylate it. Varying HSM shows that the rate of PtdEtn formation is dependent upon the amount of acceptor added.

The reconstituted transport system composed of either permeabilized cells or washed donor/acceptor membranes displays marked sensitivity to chelation of Mn2+ with EDTA. Upon the addition of EDTA, the formation of PtdEtn is immediately arrested. The requirement for Mn2+ appears specific, since other common divalent cations fail to substitute for its function. The Mn2+ requirement appears to be an uncommon aspect of lipid transport that may distinguish the process from interorganelle protein transport.

Comparison of reconstituted transport using HSM derived from psd1Delta strains and psd1Delta /pstB2 strains provides compelling evidence that the PtdSer transfer to the locus of Psd2p is specific. In vivo studies have provided clear evidence that pstB2 mutants are profoundly defective in decarboxylation of nascent PtdSer despite the presence of wild type levels of Psd2p. This same defect is reproduced with permeabilized psd1Delta /pstB2 cells. The reconstituted donor/acceptor system reveals that even in the presence of excess Psd2p in HSM, there is no significant decarboxylation of nascent PtdSer by cells harboring a pstB2 mutation. This latter result effectively rules out the occurrence of nonspecific fusion and artifactual decarboxylation in the permeabilized cell system.

The reconstituted transport system also allows for assignment of the subcellular site of action of PstB2p. Previous studies have demonstrated that PstB2p is an amphitropic protein present in both the cytosol and multiple membranes (7). The experiments described in this report demonstrate that donor membranes prepared from pstB2Delta mutant cells are fully competent to transfer nascent PtdSer to wild type acceptor membranes for the formation of PtdEtn. In contrast, wild type donor membranes cannot effectively transfer nascent PtdSer to Psd2p present in the pstB2Delta acceptor membranes. Thus, the pstB2Delta defect clearly resides in the acceptor membranes. These findings are consistent with PstB2p regulating the final steps of substrate access to the PtdSer decarboxylase.

In summary, we have defined a powerful new biochemical system for examining PtdSer transport events between the ER and the Golgi apparatus. This system should prove amenable to further dissection and reconstitution. We anticipate that this system will also facilitate the identification of the sites of function of new gene products in the lipid transport process and provide a biochemical assay system for elucidating their mechanism of action.


    FOOTNOTES

* This work was supported by National Institutes of Health Research Grants GM32453 (to D. R. V.) and GM19162 (to W. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Program in Cell Biology, Dept. of Medicine, National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206. Tel.: 303-398-1300; Fax: 303-398-1806; E-mail: voelkerd@njc.org.

Published, JBC Papers in Press, December 4, 2000, DOI 10.1074/jbc.M010278200


    ABBREVIATIONS

The abbreviations used are: PtdSer, phosphatidylserine; PtdEtn, phosphatidylethanolamine; PtdCho, phosphatidylcholine; CDP-DAG, CDP-diacylglycerol; Pssp, PtdSer synthase; Psd1p, PtdSer decarboxylase 1; Psd2p, PtdSer decarboxylase 2; Kex2p, killer expression protease 2; HSS, high speed supernatant(s); LSS, low speed supernatant(s); HSM, high speed membrane(s); ER, endoplasmic reticulum.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES


1. Voelker, D. R. (2000) Biochim. Biophys. Acta 1486, 97-107[Medline] [Order article via Infotrieve]
2. Gaigg, B., Simbeni, R., Hrastnik, C., Paltauf, F., and Daum, G. (1995) Biochim. Biophys. Acta 1234, 214-220[Medline] [Order article via Infotrieve]
3. Trotter, P. J., Pedretti, J., and Voelker, D. R. (1993) J. Biol. Chem. 268, 21416-21424[Abstract/Free Full Text]
4. Trotter, P. J., and Voelker, D. R. (1995) J. Biol. Chem. 270, 6062-6070[Abstract/Free Full Text]
5. Atkinson, K. D., Fogel, S., and Henry, S. A. (1980) J. Biol. Chem. 255, 6653-6661[Abstract/Free Full Text]
6. Trotter, P. J., Wu, W., Pedretti, J. P., Yates, R., and Voelker, D. R. (1998) J. Biol. Chem. 273, 13189-13196[Abstract/Free Full Text]
7. Wu, W. I., Routt, S., Bankaitis, V. A., and Voelker, D. R. (2000) J. Biol. Chem. 275, 14446-14456[Abstract/Free Full Text]
8. Achleitner, G., Zweytick, D., Trotter, P. J., Voelker, D. R., and Daum, G. (1995) J. Biol. Chem. 270, 29836-29842[Abstract/Free Full Text]
9. Ohta, A., Waggoner, K., Louie, K., and Dowhan, W. (1981) J. Biol. Chem. 256, 2219-2225[Free Full Text]
10. Daum, G., Böhni, P. C., and Schatz, G. (1982) J. Biol. Chem. 257, 13028-13033[Abstract/Free Full Text]
11. Carman, G., and Bae-Lee, M. (1992) Methods Enzymol. 209, 298-305[Medline] [Order article via Infotrieve]
12. Cleves, A. E., McGee, T. P., Whitters, E. A., Champion, K. M., Aitken, J. R., Dowhan, W., Goebl, M., and Bankaitis, V. A. (1991) Cell 64, 789-800[Medline] [Order article via Infotrieve]
13. Cunningham, K. W., and Wickner, W. T. (1989) Yeast 5, 25-33[Medline] [Order article via Infotrieve]
14. Trotter, P. J., Pedretti, J., Yates, R., and Voelker, D. R. (1995) J. Biol. Chem. 270, 6071-6080[Abstract/Free Full Text]
15. Voelker, D. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 9921-9925[Abstract]
16. Voelker, D. R. (1990) J. Biol. Chem. 265, 14340-14346[Abstract/Free Full Text]
17. Voelker, D. R. (1993) J. Biol. Chem. 268, 7069-7074[Abstract/Free Full Text]
18. Hay, J. C., and Scheller, R. H. (1997) Curr. Opin. Cell Biol. 9, 505-12[CrossRef][Medline] [Order article via Infotrieve]
19. Novick, P., and Zerial, M. (1997) Curr. Opin. Cell Biol. 9, 496-504[CrossRef][Medline] [Order article via Infotrieve]
20. Rothman, J. E. (1996) Protein Sci. 5, 185-194[Abstract/Free Full Text]
21. Mayr, J. A., Kohlwein, S. D., and Paltauf, F. (1996) FEBS Lett. 393, 236-240[CrossRef][Medline] [Order article via Infotrieve]
22. Waksman, M., Tang, X., Eli, Y., Gerst, J. E., and Liscovitch, M. (1997) J. Biol. Chem. 272, 36-39[Abstract/Free Full Text]
23. Voelker, D. R. (1996) in Biochemistry of Lipids, Lipoproteins and Membranes (Vance, D. E. , and Vance, J. E., eds) , pp. 391-423, Elsevier, Amsterdam


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.